HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC

Cancer control in Latin America

Assessment of cervical and breast cancer screening in Latin America and Caribbean: CanScreen5/CELAC project

Long-term breast cancer risk after benign breast disease in population-based screening

Individualised breast cancer risk assessment model for BreastScreen Norway

Intraoperative Radiotherapy

Cancer survivors' stories: An African perspective

ESMO 2022: Breast and ovarian trial analysis

ESMO 2022: Highlights, commentary and analysis

ESMO 2022: Renal roundup

Fruquintinib provides improvement in overall survival for refractory mCRC

ESMO 2022: Breast cancer highlights